Sort
17,054 grants matching “genome editing”
Epigenetic enhancer control in maintaining homeostasis and preventing carcinogenesis in the epidermis
$394,085Brian Capell · University Of Pennsylvania · R01 · FY2022 · AR
Project 5 - HIV-1 Genome Stability & Editing Mediated by Host
$394,082Paul D Bieniasz · University Of Michigan At Ann Arbor · U54 · FY2017 · GM
Determining the molecular mechanism of cell size control
$394,046Jan M Skotheim · Stanford University · R01 · FY2017 · GM
Dissecting the role of shuttling mRNA binding proteins in nucleocytoplasmic RNA transport
$393,942Markus Hafner · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2019 · AR
Integration of the results from systems-level determination of cis-acting elements into high-resolution maps of posttranscriptional regulatory events.
$393,942Markus Hafner · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2019 · AR
SusChEM: Long chain hydrocarbons from CO2 and electricity via genetic modification of a chemolithoautotrophic bacterium
$393,932Scott A Banta · Columbia University · · FY2015 · ENG
Mechanism-based strategies to target ER-mutant endocrine resistant breast cancer
$393,861Steffi Oesterreich · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
Mechanism-based strategies to target ER-mutant endocrine resistant breast cancer
$393,861Steffi Oesterreich · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA
Project 3
$393,847Paul B McCray · University Of Iowa · P01 · FY2025 · HL
Core 1 Krogan
$393,809Danielle L Swaney · University Of California, San Francisco · U54 · FY2024 · AI
Pluripotent Stem Cell Derived 3D Retinas for Studies of Early Onset Retinal Degeneration
$393,750Karl J Wahlin · University Of California, San Diego · R01 · FY2020 · EY
Kinase Multitargeting for Glaucoma Neuroprotection
$393,750Derek Stuart Welsbie · University Of California, San Diego · R01 · FY2020 · EY
Preventing MAPK inhibitor resistance in melanoma by targeting genomic instability and immune resistance
$393,750Roger S Lo · University Of California Los Angeles · R01 · FY2025 · CA
PubAssist - an NLP-based document search system
$393,750Ariadne Genomics, Inc. · R44 · FY2004 · RR
Steroid hormone dependent gene expression and neuroplasticity in the brain
$393,750Beau Alward · University Of California Los Angeles · R35 · FY2024 · GM
Kinase Multitargeting for Glaucoma Neuroprotection
$393,750Derek Stuart Welsbie · University Of California, San Diego · R01 · FY2019 · EY
Preventing MAPK inhibitor resistance in melanoma by targeting genomic instability and immune resistance
$393,750Roger S Lo · University Of California Los Angeles · R01 · FY2024 · CA
Towards Robust Multiplex Genome Engineering Beyond CRISPR-Cas9
$393,625Le Cong · Stanford University · R35 · FY2021 · HG
Determining the molecular mechanism of cell size control
$393,616Jan M Skotheim · Stanford University · R01 · FY2016 · GM
Role of APOBEC3 in in vivo Restriction of Retrovirus Infection
$393,599Susan R Ross · University Of Pennsylvania · R01 · FY2010 · AI
Unraveling the role of endothelium in chemotherapy-induced cardiotoxicity
$393,500Nazish Sayed · Stanford University · R01 · FY2024 · HL
Unraveling the role of endothelium in chemotherapy-induced cardiotoxicity
$393,500Nazish Sayed · Stanford University · R01 · FY2023 · HL
Deciphering the Endothelial Cell-Cardiomyocyte Crosstalk in LMNA Cardiomyopathy
$393,500Nazish Sayed · Stanford University · R01 · FY2021 · HL
Deciphering the Endothelial Cell-Cardiomyocyte Crosstalk in LMNA Cardiomyopathy
$393,500Nazish Sayed · Stanford University · R01 · FY2022 · HL
Unraveling the role of endothelium in chemotherapy-induced cardiotoxicity
$393,500Nazish Sayed · Stanford University · R01 · FY2022 · HL